Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-23T12:19:44.708Z Has data issue: false hasContentIssue false
  • English
  • Français

Does HIV serostatus affect outcomes of dually diagnosed opiate dependents in residential treatment?

Published online by Cambridge University Press:  18 May 2011

Giuseppe Carrà ,
Cristina Montomoli ,
Maria Cristina Monti  and
Massimo Clerici
Giuseppe Carrà
Affiliation:
Department of Mental Health Sciences, Royal Free and University College Medical School, London (UK)
Cristina Montomoli
Affiliation:
Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia (Italy)
Maria Cristina Monti
Affiliation:
Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia (Italy)
Massimo Clerici*
Affiliation:
Department of Neuro sciences and Biomedical Technologies, University of Milano, Bicocca Medical School
*
Address for correspondence: Prof. M. Clerici, Department of Neurosciences and Biomedical Technologies, University of Milano Bicocca Medical School, Via Pergolesi 33, 20052 Monza (Italy). Fax: +39(0)2 4547 1850 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Summary

Backgroung – Little is known about specific treatment needs of mentally ill clients abusing substances and infected by HIV. The major gap concerns residential programmes. Aims – To explore differences in outcomes between seropositive and seronegative dually diagnosed opiate dependent clients who participated in a residential therapy programme. Methods – Data were gathered on 154 clients treated in a therapeutic community in Milan between October 1999 and September 2004. Odds ratios with 95% confidence intervals were used to study the association between HIV serostatus and outcome. Results – At 12-month follow-up, seropositive clients were more likely to relapse. Conclusions – The impact of HIV seropositivity on behavioural outcomes should be taken into consideration when planning residential programmes for the HIV (+) dually diagnosed population. Further research could test the need of incorporating dedicated treatments into existing programmes.

Declaration of interest: None.

Keywords

Seropositivityopiate dependencemental disorderstherapeutic community
Type
Original Articles
Information
Epidemiology and Psychiatric Sciences , Volume 17 , Issue 1 , March 2008 , pp. 77 - 81
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association: Washington DC.Google Scholar
Baigent, M.F. (2003). Physical complications of substance abuse: what the psychiatrist needs to know. Current Opinion in Psychiatry 16, 291–296.CrossRefGoogle Scholar
Bizzarri, J.V., Rucci, P., Casalboni, D., Randi, S., Tattini, M., Girelli, M, Pojer, F. & Sbrana, A. (2007). Substance use and psychiatric symptoms in subjects referred to the Drug Addiction Services by the prefecture. Epidemiologia e Psichiatria Sociale 16, 73–78.CrossRefGoogle Scholar
Carrà, G. & Clerici, M. (2003). The Italian Association on Addiction Psychiatry (SIP Dip), formerly The Italian Association on Abuse and Addictive Behaviours. Addiction 98, 1039–1042.CrossRefGoogle Scholar
Carrà, G. & Clerici, M. (2006). Dual diagnosis: policy and practice in Italy. American Journal on Addictions 15, 144–149.CrossRefGoogle ScholarPubMed
Carrà, G., Scioli, R., Monti, M.C. & Marinoni, A. (2006). Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders. European Addiction Research 12,96–101.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention (CDC) (1999). Communitylevel HIV intervention in 5 cities: Final outcome data from the CDC AIDS Community Demonstration Projects. American Journal of Public Health 89, 336–345.CrossRefGoogle Scholar
Clayton, D. & Hills, M. (1993). Statistical Models in Epidemiology. Oxford University Press: Oxford.Google Scholar
Crawford, V., Crome, I.B. & Clancy, C. (2003). Co-existing problems of mental health and substance misuse (Dual Diagnosis): a literature review. Drugs: Education, Prevention and Policy 10, Suppl. 1, 1–74.Google Scholar
Crome, I.B. (2000). Dissemination of current treatment research findings to the profession, policy makers and patients-whose responsibility is it? Addiction 95, 1767–1769.Google Scholar
De Leon, G., Sacks, S., Staines, G. & McKendrick, K. (2000). Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. American Journal of Drug and Alcohol Abuse 26,461–480.CrossRefGoogle ScholarPubMed
Egelko, S., Galanter, M., Dermatis, H., Jurewicz, E., Jamison, A., Dingle, S. & De Leon, G. (2002). Improved psychological status in a modified therapeutic community for homeless MICA men. Journal of Addictive Diseases 21, 75–92.CrossRefGoogle Scholar
First, M.B., Williams, J.B., Gibbon, M. & Spitzer, R.L. (1997a). Structured Clinical Interview for DSM-IV AXIS I Disorders, Clinician Version. American Psychiatric Press: Washington.Google Scholar
First, M.B., Williams, J.B. & Spitzer, R.L. (1997b). Structured Clinical Interview for DSM-IV AXIS II Personality Disorders. American Psychiatric Press: Washington.Google Scholar
Gaughwin, M., Solomon, P. & Ali, R. (1998). Correlates of retention on the South Australian Methadone Program 1981-91. Australian and New Zealand Journal of Public Health 22, 771–776.CrossRefGoogle ScholarPubMed
Goldsmith, H.F., Wagenfeld, M.O., Manderscheid, R.W. & Stiles, D.J. (1996). Geographical distribution of organized mental health services in 1983 and 1990. In Mental Health, United States, 1996 (ed. Manderscheid, R.W. and Sonnenschein, M.A.), pp. 154–167, DHHS Publication No. SMA 96-3098. Substance Abuse and Mental Health Services Administration, Center for Mental Health Services: Rockville, MD.Google Scholar
Gonzalez, I., Rosenthal, M.S., Bigler, M.O., Alper, K. & Geringer, W. (1994). HIV antibody testing and client retention in the therapeutic community. A preliminary report of Phoenix House. Journal of Substance Abuse Treatment 11, 481–488.CrossRefGoogle ScholarPubMed
Hoff, R.A., Beam-Goulet, J. & Rosenheck, R.A. (1997). Mental disorder as a risk factor for human immunodeficiency virus infection in a sample of veterans. Journal of Nervous and Mental Disease 185, 556–560.CrossRefGoogle Scholar
Hunt, G.E., Bergen, J. & Bashir, M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research 54, 253–264.CrossRefGoogle ScholarPubMed
Kelley, J.L. & Petry, N.M. (2000). HIV risk behaviors in male substance abusers with and without antisocial personality disorder. Journal of Substance Abuse Treatment 19, 59–66.CrossRefGoogle ScholarPubMed
Kingree, J.B., Glasford, M.T. & Jones-Allen, M. (1997). A comparison of HIV-positive and HIV-negative crack users enrolled in a residential addiction treatment program. American Journal of Drug and Alcohol Abuse 23, 569–580.CrossRefGoogle Scholar
Margolese, H.C., Malchy, L., Negrete, J.C., Tempier, R. & Gill, K. (2004). Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research 67, 157–166.CrossRefGoogle ScholarPubMed
Meade, C.S. & Sikkema, K.J. (2005). HIV risk behavior among adults with severe mental illness: a systematic review. Clinical Psychology Review 25, 433–457.CrossRefGoogle ScholarPubMed
Nuttbrock, L.A., Rahav, M., Rivera, J.J., Ng-Mak, D.S. & Link, B.G. (1998). Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatric Services 49, 68–76.CrossRefGoogle Scholar
Pani, P.P., Trogu, E., Contu, P., Agus, A. & Gessa, G.L. (1997). Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug and Alcohol Dependence 48, 119–126.CrossRefGoogle Scholar
Sacks, S., Sacks, J.Y. & De Leon, G. (1999). Treatment for MICAs: design and implementation of the modified TC. Journal of Psychoactive Drugs 31, 19–30.CrossRefGoogle ScholarPubMed
Schilling, R.F., El-Bassel, N., Schinke, S.P., Gordon, K. & Nichols, S. (1991). Building skills of recovering women drug users to reduce heterosexual AIDS transmission. Public Health Reports 106, 297–304.Google ScholarPubMed
Schlesinger, M. & Dorwart, R.A. (1992). Falling between the cracks: Failing national strategies for the treatment of substance abuse. Daedalus 121, 195–237.Google Scholar
Sikkema, K.J., Meade, C.S., Doughty-Berry, J.D., Zimmerman, S.O., Kloos, B. & Snow, D.L. (2007). Community-level HIV prevention for persons with severe mental illness living in supportive housing programs: a pilot intervention study. Journal of Prevention & Intervention in the Community 33, 121–135.CrossRefGoogle ScholarPubMed
Stata Corporation. (2003). Stata Statistical Software: Release 8.0. Stata Corporation: College Station, TX.Google Scholar
Weiser, S.D., Wolfe, W.R. & Bangsberg, D.R. (2004). The HIV epidemic among individuals with mental illness in the United States. Current HIV/AIDS Reports 1, 186–192.CrossRefGoogle Scholar
Winett, R.A., Anderson, E.S., Desiderato, L.L., Solomon, L.J., Perry, M., Kelly, J.A., Sikkema, K.J., Roffman, R.A., Norman, A.D., Lombard, D.N. & Lombard, T.N. (1995). Enhancing social diffusion theory as a basis for prevention intervention: A conceptual and strategic framework. Applied and Preventive Psychology 4, 233–245.CrossRefGoogle Scholar
Zisook, S., Peterkin, J., Goggin, K.J., Sledge, P., Atkinson, J.H. & Grant, I. (1998). Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. Journal of Clinical Psychiatry 59, 217–224.Google ScholarPubMed